Active	Status	Sponsor type	Region	Phase	Filter
5 Active 1 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wigg, Alan
TEMPO, NCT04014179: Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs	Recruiting	N/A	2700	RoW	Xpert HCV Viral Load Fingerstick, Aptima HCV Quant DX Assay	Kirby Institute	Hepatitis C, Hepatitis C, Chronic	12/25	12/25
NCT05042544: The National Australian HCV Point-of-Care Testing Program	Recruiting	N/A	40000	RoW	Point-of-Care Testing	Kirby Institute, Flinders University	Hepatitis C	12/24	12/26
Warner, Morgyn
diSArm, NCT05184764: Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia	Recruiting	1/2	50	US, RoW	AP-SA02, Placebo	Armata Pharmaceuticals, Inc., United States Department of Defense	Bacteremia, Staphylococcus Aureus, Staphylococcus Aureus Bacteremia, Bacteremia Staph, Bacteremia Due to Staphylococcus Aureus	12/24	03/25
TEMPO, NCT04014179: Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs	Recruiting	N/A	2700	RoW	Xpert HCV Viral Load Fingerstick, Aptima HCV Quant DX Assay	Kirby Institute	Hepatitis C, Hepatitis C, Chronic	12/25	12/25
NCT05042544: The National Australian HCV Point-of-Care Testing Program	Recruiting	N/A	40000	RoW	Point-of-Care Testing	Kirby Institute, Flinders University	Hepatitis C	12/24	12/26